MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform

Rhea-AI Summary

MediThinQ and Synovis Micro Companies Alliance, a Baxter (NYSE:BAX) subsidiary, signed an exclusive multi-year global distribution agreement for the SHIYA 3D surgical visualization platform. The deal leverages Synovis MCA’s microsurgery network to support phased worldwide rollout and adoption of digital, data-enabled 3D exoscope-based microsurgery.

Positive

• Exclusive multi-year global distribution agreement for SHIYA platform
• Access to Synovis MCA’s established microsurgery customer and clinical network
• Phased international rollout aligned with local regulatory requirements
• SHIYA reportedly used in over 100 procedures with peer-reviewed support
• Digital 3D exoscope and wearable display enable heads-up microsurgery
• Platform designed to support data capture for AI and robotic-assisted surgery

Negative

• Financial terms of the distribution agreement were not disclosed
• Global rollout will be phased rather than immediate across all markets

News Market Reaction – BAX

+2.58%

+2.58% Session close to close

In the Jun 18 session, BAX gained 2.58%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Baxter’s role distributing MediThinQ’s SHIYA platform, already used in ...

Analysis

This announcement highlights Baxter’s role distributing MediThinQ’s SHIYA platform, already used in over 100 procedures with up to 20x magnification. Recent filings show active institutional ownership and insider equity grants, while elevated short interest adds volatility risk.

Key Figures

Magnification capability: up to 20x Clinical usage: more than 100 procedures Review article year: 2025 +1 more

4 metrics

Magnification capability up to 20x SHIYA digital exoscope system specification

Clinical usage more than 100 procedures Global use of SHIYA to date

Review article year 2025 JPRAS Open review on digital exoscope systems in microsurgery

PRS publication year 2026 Plastic and Reconstructive Surgery paper on 3D exoscopes with heads-up displays

Historical Context

5 past events · Latest: 2026-05-05 ()

5 events

Date	Event	Sentiment	24h Move	Catalyst
2026-05-05	management		+0.8%	Board appointments and strategic financing update at 4D Path affiliate.
2026-04-30	news		+4.0%	First-quarter 2026 financial results for Baxter International Inc.
2026-04-13	news		+2.8%	Showcase of recent surgical innovations at AORN 2026 conference.
2026-04-08	conferences,earnings		+0.3%	Announcement of upcoming Q1 2026 financial results conference call.
2026-03-30	news		-1.1%	Launch of IV Verify Line Labeling System via distribution agreement.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

digital exoscope, heads-up displays, supermicrosurgery, telemicrosurgery, +1 more

5 terms

digital exoscope technical

"MediThinQ developed SHIYA to address these limitations through a fully digital surgical platform. The system combines a high-resolution digital exoscope with up to 20x magnification"

A digital exoscope is a high-resolution external camera system used in operating rooms to provide magnified, often 3D, real-time views of surgical sites on a screen, replacing or supplementing traditional operating microscopes. Investors should care because hospitals buy these devices to improve surgical precision, training, and ergonomics—driving capital equipment sales, software and service subscriptions, and potential follow-on upgrades that affect a medical device maker’s revenue and growth.

heads-up displays technical

"examining the portability and ergonomic advantages of 3D exoscopes equipped with heads-up displays – SHIYA's core offering"

A heads-up display (HUD) is a transparent screen or projection that presents key information directly in a user’s line of sight—like speed, navigation, or alerts on a car windshield—so the user can stay focused on their surroundings. Investors care because HUDs are a visible feature that can boost product value, differentiate competitors, and signal demand for software, sensors, and hardware that drive revenue and aftermarket sales.

supermicrosurgery medical

"Their findings support the viability of such platforms as an alternative to the conventional microscope, and point to potential applications in supermicrosurgery, telemicrosurgery, as well as robotic-assisted procedures"

Supermicrosurgery is a surgical technique that uses very high-magnification tools and tiny instruments to repair or connect blood vessels and nerves often thinner than a human hair. For investors, it matters because this specialized approach can enable new treatments, improve patient outcomes, shorten recovery times, and drive demand for advanced surgical tools, training, and reimbursement — factors that affect the commercial value of related medical devices and services.

telemicrosurgery medical

"applications in supermicrosurgery, telemicrosurgery, as well as robotic-assisted procedures"

Telemicrosurgery is performing very small, precise surgical procedures with a surgeon controlling robotic instruments from a remote location over a data link, much like steering a high-precision remote-controlled device while watching a live video feed. It matters to investors because it can expand access to specialized care, change cost structures, and create demand for surgical robots, secure networks, and new reimbursement models—factors that can affect the value and growth prospects of healthcare and technology companies.

3d surgical intelligence technical

"MediThinQ is also advancing a broader concept of "3D Surgical Intelligence" aimed at integrating visualization, data capture, and analytics"

A technology that combines three‑dimensional imaging with machine learning and real‑time tracking to help surgeons plan and perform operations more precisely; think of it as a GPS and smart assistant for the operating room that shows a live 3D map of anatomy and highlights optimal paths and potential risks. For investors, it matters because it can shorten procedures, reduce complications and costs, and create recurring revenue through software, hardware and data services, potentially improving hospital adoption and margins for providers that sell or license the technology.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Multi-year exclusive agreement to expand access to next-generation 3D surgical visualization worldwide

SEOUL, South Korea, June 18, 2026 /PRNewswire/ -- MediThinQ, a South Korea-based innovator in surgical visualization technologies, has entered into an exclusive multi-year distribution agreement with Synovis Micro Companies Alliance, Inc. ("Synovis MCA"), a subsidiary of Baxter International Inc. (NYSE:BAX) and trusted leader in microsurgical devices and solutions, to commercialize SHIYA, its 3D surgical visualization platform. Terms of this agreement were not disclosed.

The agreement enables the global rollout of SHIYA through Synovis MCA, leveraging the company's deep-rooted expertise in microsurgery and its longstanding relationships with leading hospitals and world-renowned reconstructive surgeons. With a presence across key international markets and a reputation built over more than three decades, Synovis MCA provides a highly specialized commercial and clinical platform to accelerate adoption of SHIYA worldwide. Synovis MCA is uniquely positioned to support the continued evolution of microsurgery from conventional optical microscopes toward advanced digital visualization systems.

From Optical Constraints to Data-Enabled Surgical Environments

Surgical visualization has long depended on optical microscopes, requiring surgeons to operate through fixed eyepieces. While effective, this approach can constrain posture, limit visibility across the surgical team, and restrict how procedures are captured, analyzed, and taught.

MediThinQ developed SHIYA to address these limitations through a fully digital surgical platform. The system combines a high-resolution digital exoscope with up to 20x magnification and its proprietary wearable display, SCOPEYE, allowing surgeons to operate without reliance on traditional eyepieces.

By transitioning from optical to digital visualization, SHIYA enables a fundamental shift in how surgical data is generated and used. Unlike optical systems, where visual information is largely confined to the surgeon, digital platforms allow procedures to be captured, stored, and shared in real time. This capability is increasingly seen as foundational for the development of data-driven surgery, including applications in artificial intelligence, advanced analytics, and robotic-assisted procedures.

In parallel, the heads-up and wearable configuration supports more ergonomic surgical workflows and shared visibility across the operating team. The platform's portability and flexible deployment capabilities also address access challenges associated with conventional microscopes, which remain costly and infrastructure-intensive, particularly in resource-constrained settings.

Clinical Validation and Surgical Perspective

To date, SHIYA has been used in more than 100 procedures globally, with findings supported by peer-reviewed research. A 2025 review article published in JPRAS Open, led by Prof. Joon-pio Hong, Chief Medical Officer of MediThinQ and President of the World Society for Reconstructive Microsurgery, examined the role of digital exoscope systems in microsurgery and noted their potential to support emerging applications such as augmented and data-assisted surgical techniques.

Separately, a team led by Dr. Hyung Bae Kim, Clinical Assistant Professor in the Department of Plastic Surgery at Asan Medical Center, has published a paper in Plastic and Reconstructive Surgery (PRS 2026) examining the portability and ergonomic advantages of 3D exoscopes equipped with heads-up displays – SHIYA's core offering. Their findings support the viability of such platforms as an alternative to the conventional microscope, and point to potential applications in supermicrosurgery, telemicrosurgery, as well as robotic-assisted procedures.

"Digital visualization is not simply an incremental improvement over conventional microscopes – it fundamentally changes how surgeons interact with the operative field," said Prof. Hong. "The ability to operate in a heads-up position while sharing the same visual field with the entire team has important implications for precision, training, and surgical ergonomics."

Dr. Peter Neligan, Professor Emeritus of Surgery at the University of Washington and a globally recognized leader in reconstructive microsurgery, has described SHIYA as "the future of reconstructive microsurgery."

Scaling Access to Digital Surgical Visualization

The collaboration with Synovis MCA provides commercial infrastructure capabilities to scale SHIYA globally, enabling broader adoption of digital surgical visualization across diverse healthcare systems. By leveraging Synovis MCA's deep clinical expertise in microsurgery and its trusted relationships with leading surgeons, MediThinQ is well-positioned to accelerate adoption and ensure SHIYA meets the real-world needs of complex reconstructive procedures. Rather than an immediate worldwide launch, the rollout will be phased over time, tailored carefully to specific regulatory requirements and market readiness in each respective country.

Seung Joon IM, Founder and CEO of MediThinQ, said the partnership reflects the original vision behind the company:

"MediThinQ was founded on the belief that surgeons should not be constrained by the limitations of optical systems. This agreement is an important step in making digital surgical visualization more widely accessible – so that more surgeons, in more settings, can benefit from improved ergonomics, better visibility, and new ways of working."

Michael Campbell, President of Synovis MCA, shared his perspective on the collaboration and value of SHIYA:

"We are honored to work with MediThinQ as their global partner in launching their breakthrough digital vision technology, SHIYA. SHIYA is aligned to our mission of being "the microsurgeon's most trusted resource" by delivering innovative solutions that are safer, efficient, and more effective.

We look forward to building a strong foundation of growth and value supported by our core value of trust, mutual respect, high communication and a spirit of cooperation. Together we are creating the future of microsurgery."

MediThinQ is also advancing a broader concept of "3D Surgical Intelligence" aimed at integrating visualization, data capture, and analytics into a connected surgical environment.

About MediThinQ

MediThinQ is a South Korea-based medical technology company developing proprietary imaging technologies that enable the digital transformation of operating rooms. Through its wearable display solution SCOPEYE and digital exoscope SHIYA, the company delivers immersive and ergonomic surgical environments designed to enhance precision, collaboration, and workflow efficiency. MediThinQ continues to expand its global regulatory footprint, having secured relevant product approvals in key global markets including the United States, Europe, Japan, China, South Korea, the United Kingdom, Australia, and Taiwan based on respective market configurations.

About Synovis Micro Companies Alliance, Inc.

Synovis Micro Companies Alliance, Inc. (Synovis MCA), a subsidiary of Baxter International Inc., is a leading provider of advanced technologies and devices dedicated to reconstructive microsurgery. The company's mission is to be the microsurgeon's most trusted partner by delivering innovative, high-quality solutions that support precision, efficiency, and improved patient outcomes in complex procedures. Through its globally recognized product portfolio and strong relationships with surgeons and hospitals worldwide, Synovis MCA continues to advance the field of microsurgery and enable clinicians to deliver life-enhancing care.

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medithinq-and-synovis-micro-companies-alliance-inc-announce-strategic-global-distribution-agreement-to-redefine-microsurgery-with-the-shiya-3d-visualization-platform-302803902.html

SOURCE MediThinQ

FAQ

What did Baxter’s subsidiary Synovis MCA announce about the SHIYA platform on June 18, 2026 (BAX)?

Synovis MCA announced an exclusive multi-year global distribution agreement for MediThinQ’s SHIYA 3D surgical visualization platform. According to MediThinQ, the partnership aims to expand access to digital exoscope-based microsurgery through Synovis MCA’s worldwide clinical and commercial infrastructure.

How does the SHIYA 3D visualization platform work in microsurgery for Baxter-linked Synovis MCA (BAX)?

SHIYA combines a high-resolution digital exoscope with up to 20x magnification and a SCOPEYE wearable display. According to MediThinQ, this enables heads-up surgery, shared team visibility, and real-time data capture compared with traditional optical microscopes’ fixed eyepieces.

What clinical experience and research support the SHIYA 3D system associated with Baxter (BAX)?

SHIYA has reportedly been used in more than 100 procedures with findings in peer-reviewed journals. According to MediThinQ, published work highlights portability, ergonomic benefits, and potential use in supermicrosurgery, telemicrosurgery, and robotic-assisted procedures as an alternative to conventional microscopes.

How will the SHIYA distribution agreement impact global market access for Baxter-related Synovis MCA (BAX)?

The agreement allows Synovis MCA to lead SHIYA’s phased global rollout using its established microsurgery footprint. According to MediThinQ, country launches will be tailored to local regulatory requirements and market readiness, aiming to broaden access across diverse healthcare systems.

What surgical advantages does SHIYA claim over conventional microscopes for Baxter-linked Synovis MCA (BAX)?

SHIYA is designed to reduce posture constraints and improve shared visualization via a heads-up, wearable display configuration. According to MediThinQ, its digital setup supports data capture, teaching, ergonomic workflows, and integration with emerging AI and robotic-assisted surgery environments.

What is MediThinQ’s concept of 3D Surgical Intelligence in relation to Baxter’s network (BAX)?

MediThinQ describes 3D Surgical Intelligence as integrating visualization, data capture, and analytics into a connected surgical environment. According to MediThinQ, SHIYA’s digital platform is intended as a foundation for data-driven, AI-enabled and potentially robotic-assisted microsurgical workflows.